Status:
COMPLETED
Cabergoline Reduces OHSS
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
FEMALE
18-35 years
Phase:
PHASE3
Brief Summary
The present study was designed to provide clinical confirmation of Cb2's value as a new approach in the prevention of increased vascular permeability and hemoconcentration, both signs of OHSS in human...
Detailed Description
Patients and Study design This study was performed in 82 oocyte donors between April 2004 and July 2006. The study protocol was approved by our institution's Ethical Committee and all participants sig...
Eligibility Criteria
Inclusion
- 18 - 35 years old healthy women, with risk of developing OHSS.
Exclusion
- No risk of developing OHSS; \< 20 oocytes retrieved.
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00440258
Start Date
April 1 2004
End Date
July 1 2006
Last Update
February 27 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.